Patent: 4,994,370
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 4,994,370
Title: | DNA amplification technique |
Abstract: | A modification of the polymerase chain reaction (PCR) technique is described. The method allows the amplification of regions of DNA flanking a single region of known sequence, in contrast to standard PCR which requires two regions of known sequence at opposite ends of the fragment to be amplified. Various advantages of the new method are described. |
Inventor(s): | Silver; Jonathan (Bethesda, MD), Keerikatte; Vijaya R. (Bethesda, MD) |
Assignee: | The United States of America as represented by the Department of Health (Washington, DC) |
Application Number: | 07/292,814 |
Patent Claims: | see list of patent claims |
Details for Patent 4,994,370
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | See Plans and Pricing | 2039-02-26 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | See Plans and Pricing | 2039-02-26 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | See Plans and Pricing | 2039-02-26 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |